UBS Group
AKLI

UBS Group’s Akili Inc AKLI Stock Holding History

UBS Group’s Portfolio AKLI Stock Details AKLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,670
Closed -$2.8K – 10321
2024
Q1 		$2.8K Buy
+9,670
New +$3.01K ﹤0.01% 7825
2023
Q2 		– Sell
-8,255
Closed -$13.2K – 9957
2023
Q1 		$13.2K Sell
8,255
-13,463
-62% -$21K ﹤0.01% 7410
2022
Q4 		$24.3K Buy
21,718
+19,067
+719% +$33.6K ﹤0.01% 7450
2022
Q3 		$6K Sell
2,651
-987
-27% -$7.08K ﹤0.01% 9100
2022
Q2 		$36K Buy
3,638
+1,633
+81% +$16.1K ﹤0.01% 6205
2022
Q1 		$20K Buy
+2,005
New +$19.8K ﹤0.01% 7468
2021
Q4 		– Sell
-1,754
Closed -$17K – 10884
2021
Q3 		$17K Buy
+1,754
New +$17.3K ﹤0.01% 7363

Other funds holding AKLI

SCG
Social Capital Group Menlo Park, California $5.16M AUM 66.85% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

UBS Group's AKLI Position: Q2 2024 in Review

UBS Group sold out of Akili Inc (AKLI) in Q2 2024, closing a stake of 9,670 shares — an estimated $2.8K sold.

UBS Group first reported a position in AKLI in Q3 2021 and held it in 7 quarters. The position peaked at $36K in Q2 2022. 35 funds tracked by Wall St. Rank hold AKLI as of Q2 2024.

  • UBS Group reported no remaining Akili Inc position as of Q2 2024 after selling out during the quarter.
  • UBS Group sold 9,670 Akili Inc shares in Q2 2024, an estimated $2.8K.
  • UBS Group first reported a position in Akili Inc in Q3 2021 and held it in 7 quarters.
  • UBS Group's Akili Inc position peaked at $36K in Q2 2022.
  • 35 funds tracked by Wall St. Rank held Akili Inc as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.